Works matching IS 00207136 AND DT 2022 AND VI 150 AND IP 6

Results: 17
    1
    2
    3

    Genetically determined cutaneous nevi and risk of cancer.

    Published in:
    International Journal of Cancer, 2022, v. 150, n. 6, p. 961, doi. 10.1002/ijc.33874
    By:
    • Dusingize, Jean Claude;
    • Law, Matthew H.;
    • Pandeya, Nirmala;
    • Neale, Rachel E.;
    • Ong, Jue‐Sheng;
    • MacGregor, Stuart;
    • Whiteman, David C.;
    • Olsen, Catherine M.
    Publication type:
    Article
    4

    The clinical utility and safety of short‐course immune checkpoint inhibitors in multiple tumours—A real‐world multicentric study from India.

    Published in:
    International Journal of Cancer, 2022, v. 150, n. 6, p. 1045, doi. 10.1002/ijc.33868
    By:
    • Abraham, George;
    • Noronha, Vanita;
    • Rajappa, Senthil;
    • Agarwal, Amit;
    • Batra, Ullas;
    • Somani, Naresh;
    • Raja, Thirumalairaj;
    • Patil, Shekhar;
    • Kaushal, Ashish M.;
    • Joshi, Ashish;
    • Radhakrishnan, Vivek;
    • Singh, Navneet;
    • Babu, Govind;
    • Tewani, Rohan;
    • Baghmar, Saphalta;
    • Dodagoudar, Chandragouda;
    • Ananthakrishnan, Ramya;
    • Haragadde Poppareddy, Shashidhara;
    • Sharma, Vibhor;
    • Menon, Nandini
    Publication type:
    Article
    5

    Pazopanib with 5‐FU and oxaliplatin as first line therapy in advanced gastric cancer: A randomized phase‐II study—The PaFLO trial. A study of the Arbeitsgemeinschaft Internistische Onkologie AIO‐STO‐0510.

    Published in:
    International Journal of Cancer, 2022, v. 150, n. 6, p. 1007, doi. 10.1002/ijc.33864
    By:
    • Högner, Anica;
    • Al‐Batran, Salah‐Eddin;
    • Siveke, Jens T.;
    • Lorenz, Mario;
    • Bartels, Prisca;
    • Breithaupt, Kirstin;
    • Malfertheiner, Peter;
    • Homann, Nils;
    • Stein, Alexander;
    • Gläser, Dietrich;
    • Tamm, Ingo;
    • Hinke, Axel;
    • Vogel, Arndt;
    • Thuss‐Patience, Peter
    Publication type:
    Article
    6
    7

    Safety, pharmacokinetic, pharmacodynamic and clinical activity of molibresib for the treatment of nuclear protein of the testis carcinoma and other cancers: Results of a Phase I/II open‐label, dose escalation study.

    Published in:
    International Journal of Cancer, 2022, v. 150, n. 6, p. 993, doi. 10.1002/ijc.33861
    By:
    • Cousin, Sophie;
    • Blay, Jean‐Yves;
    • Garcia, Irene Braña;
    • de Bono, Johann S.;
    • Le Tourneau, Christophe;
    • Moreno, Victor;
    • Trigo, Jose;
    • Hann, Christine L.;
    • Azad, Arun A.;
    • Im, Seock‐Ah;
    • Cassier, Philippe A.;
    • French, Christopher A.;
    • Italiano, Antoine;
    • Keedy, Vicki L.;
    • Plummer, Ruth;
    • Sablin, Marie‐Paule;
    • Hemming, Matthew L.;
    • Ferron‐Brady, Geraldine;
    • Wyce, Anastasia;
    • Khaled, Ahmed
    Publication type:
    Article
    8
    9
    10
    11
    12

    Issue Information.

    Published in:
    International Journal of Cancer, 2022, v. 150, n. 6, p. 1067, doi. 10.1002/ijc.33633
    Publication type:
    Article
    13
    14
    15
    16

    Issue Information.

    Published in:
    International Journal of Cancer, 2022, v. 150, n. 6, p. 897, doi. 10.1002/ijc.33634
    Publication type:
    Article
    17

    Oral and gastric microbiome in relation to gastric intestinal metaplasia.

    Published in:
    International Journal of Cancer, 2022, v. 150, n. 6, p. 928, doi. 10.1002/ijc.33848
    By:
    • Wu, Fen;
    • Yang, Liying;
    • Hao, Yuhan;
    • Zhou, Boyan;
    • Hu, Jiyuan;
    • Yang, Yaohua;
    • Bedi, Sukhleen;
    • Sanichar, Navin Ganesh;
    • Cheng, Charley;
    • Perez‐Perez, Guillermo;
    • Tseng, Wenche;
    • Tseng, Wenzhi;
    • Tseng, Mengkao;
    • Francois, Fritz;
    • Khan, Abraham R.;
    • Li, Yihong;
    • Blaser, Martin J.;
    • Shu, Xiao‐ou;
    • Long, Jirong;
    • Li, Huilin
    Publication type:
    Article